NSE : GUFICBIO.NS

Gufic Biosciences Limited

$378.85 INR

$1.7 (0.45%)

Volume
47.08K
Average Volume
274.03K
Market Capitalization
$37.99B
P/E Ratio
59.20
Dividend Yield
0.03%
Price Target
Year High
$448.00
Year Low
$268.00
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$1.55
Company Overview

NSE

Pranav Jayesh Choksi

Drug Manufacturers - Specialty & Generic

Healthcare

GUFICBIO.NS

1491

IN

INR

https://gufic.com

91 22 6726 1000

Y28251125

N/A

Liquidity Metrics

0.61

1.55

0.92

0.15

0.00

Sales & Valuation

$9.44B

4.02

5.72

87.37

4.33

Profitability

$6.4

$642.15M

6.80%

9.17%

10.16%

4.78%

P/E Metrics

59.20

-7.48

-7.48

Analyst Price Target & Rating

Sell

2/5

0 Analysts

%

Financial Health Scores

4.62

6/9

$2.84B

$13.42B

$6.77B

$1.22B

Key Metrics (TTM)

No key metrics data available.

Company Executives
Name Title
Pranav Jayesh Choksi Chief Executive Officer & Whole Time Director
Avik Das Investor Relations Officer
Devkinandan Roonghta Chief Financial Officer
Pinak Padhya Associate Vice President - Sales & Marketing
Sunil Desai Head – Human Resource Department
Ashok Dev President of Operation
Ami Naresh Shah Senior Manager of Legal, Company Secretary & Compliance Officer
Jayesh Pannalal Choksi Chairman & MD
Nagesh Yarrabathina Chief Operating Officer
Pankaj Jayakumar Gandhi Whole-Time Director
Poll Results

No votes yet today — be the first to share your view!

About Gufic Biosciences Limited (NSE:GUFICBIO.NS) Stock

Gufic Biosciences Limited is an Indian enterprise dedicated to the manufacturing and marketing of active pharmaceutical ingredients (APIs), generic medications, and related support services. The company's API and bulk drug offerings include antifungals, anesthetics, immunosuppressants, and intermediates for antifungal treatments. It also produces lyophilized injectable pharmaceuticals, covering diverse therapeutic areas such as antibiotics, antifungals, cardiac care, infertility solutions, antivirals, and proton-pump inhibitors. Additionally, Gufic Biosciences provides pharmaceutical products under its Spark, Criti Care, and Ferti Care brands, as well as a line of herbal and personal care items. The company distributes its extensive product portfolio to hospital networks and medical facili ... ties, and it exports its goods to over twenty countries globally. Established in 1970, Gufic Biosciences Limited is headquartered in Mumbai, India.

Frequently Asked Questions

What is the current Gufic Biosciences Limited (GUFICBIO.NS) stock price?

Gufic Biosciences Limited(NSE:GUFICBIO.NS) stock price is $378.85 in the last trading session. During the trading session, GUFICBIO.NS stock reached the peak price of $448 while $268 was the lowest point it dropped to. The percentage change in GUFICBIO.NS stock occurred in the recent session was 0.45% while the dollar amount for the price change in GUFICBIO.NS stock was $1.7.

GUFICBIO.NS's industry and sector of operation?

The NSE listed GUFICBIO.NS is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.

Who are the executives of GUFICBIO.NS?

Pranav Jayesh Choksi | Chief Executive Officer & Whole Time Director
Avik Das | Investor Relations Officer
Devkinandan Roonghta | Chief Financial Officer
Pinak Padhya | Associate Vice President - Sales & Marketing
Sunil Desai | Head – Human Resource Department

How many employees does GUFICBIO.NS have?

Number of GUFICBIO.NS employees currently stands at 1491. GUFICBIO.NS operates from SM House, Mumbai, MA 400057, IN.

Link for GUFICBIO.NS official website?

Official Website of GUFICBIO.NS is: https://gufic.com

How do I contact GUFICBIO.NS?

GUFICBIO.NS could be contacted at phone #91 22 6726 1000 and can also be accessed through its website. GUFICBIO.NS operates from SM House, Mumbai, MA 400057, IN.

How many shares of GUFICBIO.NS are traded daily?

The average number of GUFICBIO.NS shares traded daily for last 3 months was 274.03K.

What is the market cap of GUFICBIO.NS currently?

The market value of GUFICBIO.NS currently stands at $37.99B with its latest stock price at $378.85